Zhejiang Huahai Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ELAGOLIX SODIUM, with a corresponding US DMF Number 36627.
Remarkably, this DMF maintains an Active status since its submission on December 30, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 20, 2022, and payment made on December 27, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II